|
Devicemakers: FDA Manipulated Panel to Keep Depression Therapy in Class III
Makers of cranial electrotherapy stimulators (CES) are crying foul in the wake of an FDA advisory panel meeting that ruled against reclassifying the devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives